The osteoporosis prevalence among the country’s women aged less than 50 was less than 5%. The prevalence of this disease increased after the age of 50. The following table shows the age-specific prevalence of osteopenia and osteoporosis.
The rising disposable income, increasing awareness about health & wellness, and increasing awareness are among the major factors contributing to the women’s health market growth in the country.
For instance, in April 2023, Fuji Pharma launched Nextstellis (FSN-013) used for the prevention of pregnancy in Thailand. It is introduced to reduce the adverse effects of a combination of drugs containing estrogen.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account